Furthermore, in comparison with HFD-fed C57 WT mice, HFD-fed APP/PS1 demonstrated aggregated hyperglycemia, hypercholesterolemia, hyperinsulinemia, and enhanced hepatic lipid deposition, accompanied by decreased GLUTs expression in liver and skeletal muscle (Figure 2). The gene discussed is APP; the disease is Hyperglycemia.